Entero Therapeutics, Inc.
Entero Therapeutics, Inc. (ENTO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ento · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.85
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.71 | ↓ 5.00% |
1-day model range: $2.66–$2.76. Peak: $2.76 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -40.9% |
| 2028 | $1 | -53.0% |
| 2029 | $1 | -57.8% |
| 2030 | $1 | -60.0% |
| 2031 | — | -61.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ENTO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-03-15 | Roth MKM | Maintains | Buy→Buy |
| 2024-01-03 | Roth MKM | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Entero Therapeutics, Inc. (ENTO) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover ENTO.
Analyst Recommendation Trends
ENTO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-3.39
EPS Next Year
$-4.56
↑ 34.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ENTO EPS of $-3.39 for the current fiscal year, based on estimates from 1 analysts. The ENTO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ENTO stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ENTO price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The ENTO short-term stock prediction for tomorrow is $2.71 (-5.00%). The ENTO stock price prediction for 2027 estimates an average of $2. The ENTO stock prediction for 2030 projects a range of $1–$1.
Entero Therapeutics, Inc. trades on NASDAQ under the ticker ENTO. The ENTO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ENTO forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month ENTO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $2.85.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.